159 related articles for article (PubMed ID: 3898831)
1. The debate over substitution policy. Its evolution and scientific basis.
Schwartz LL
Am J Med; 1985 Aug; 79(2B):38-44. PubMed ID: 3898831
[TBL] [Abstract][Full Text] [Related]
2. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
Marsh DA; Hoar ME
Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
[TBL] [Abstract][Full Text] [Related]
3. Critical therapeutic categories: a contraindication to generic substitution?
Colaizzi JL; Lowenthal DT
Clin Ther; 1986; 8(4):370-9. PubMed ID: 3731208
[TBL] [Abstract][Full Text] [Related]
4. Product selection, bioequivalence, and therapeutic equivalence: the generic drug market.
Halperin JA
Drug Inf J; 1983; 17(2):73-6. PubMed ID: 10263719
[TBL] [Abstract][Full Text] [Related]
5. Generic drugs and the prescribing physician.
Nightingale SL; Morrison JC
JAMA; 1987 Sep; 258(9):1200-4. PubMed ID: 3626003
[TBL] [Abstract][Full Text] [Related]
6. Generic drugs in reproductive medicine: is the value anticipated the value obtained?
Keith LG; Method MW
Int J Fertil; 1987; 32(4):268-78. PubMed ID: 2887523
[TBL] [Abstract][Full Text] [Related]
7. A generic drug primer: regulatory aspects and scientific concepts.
Henderson JD; White GL
Mil Med; 1998 Apr; 163(4):193-7. PubMed ID: 9575760
[TBL] [Abstract][Full Text] [Related]
8. Status of generic substitution: problematic drug classes reviewed.
Ross MB
Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
[TBL] [Abstract][Full Text] [Related]
9. Generic vs. brand name drugs--defining and enforcing standards.
Lasagna LC
Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
[No Abstract] [Full Text] [Related]
10. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
Bongiorno RA; Nutescu EA
Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
[TBL] [Abstract][Full Text] [Related]
11. Prescription prices under the New York generic substitution law.
Francetić I; Lasagna L; Weintraub M; Karch FE
Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
[TBL] [Abstract][Full Text] [Related]
12. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
13. Access to generic drugs in the 1950s: the politics of a social problem.
Facchinetti NJ; Dickson WM
Am J Public Health; 1982 May; 72(5):468-75. PubMed ID: 7065335
[TBL] [Abstract][Full Text] [Related]
14. Physicians' attitudes toward generic drug substitution by pharmacists.
Brust M; Hawkins CF; Grayson D
Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
[TBL] [Abstract][Full Text] [Related]
15. A physician survey on generic drugs and substitution of critical dose medications.
Banahan BF; Kolassa EM
Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664
[TBL] [Abstract][Full Text] [Related]
16. Generic equivalence and non-equivalence of drugs.
Smith RN
Lancet; 1972 Sep; 2(7776):528-30. PubMed ID: 4115582
[No Abstract] [Full Text] [Related]
17. Pharmacy and generic substitution of antiepileptic drugs: missing in action?
Welty TE
Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833
[TBL] [Abstract][Full Text] [Related]
18. Generic drugs in dermatology: part II.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
[TBL] [Abstract][Full Text] [Related]
19. Prescription drug product substitution decision support.
Manolakis PG
J Am Pharm Assoc (2003); 2007; 47(3):328-38. PubMed ID: 17510028
[TBL] [Abstract][Full Text] [Related]
20. Genesis of generic drugs.
Calesnick B; Kreider LA; Dinan A
Pa Med; 1986 Dec; 89(12):32, 34, 36. PubMed ID: 3808720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
